First People's Hospital

Latest clinical program signals indexed for First People's Hospital.

1. XMDYYYXYK-12 — Phase 2

   Jun 8, 2026
   Clinical update →

2. 2025-SR-813 — Phase 2

   Jun 8, 2026
   Clinical update →

3. 13914704178 — Phase 2

   Jun 8, 2026
   Clinical update →

4. 09 — Phase 3

   Jun 8, 2026
   Clinical update →

5. Ommaya 02 — Phase 2

   Jun 8, 2026
   Clinical update →

6. 2025-206 — Phase 2

   Jun 8, 2026
   Clinical update →

7. 20170512 — Phase 2

   Jun 8, 2026
   Clinical update →

8. SYSUCC-CMY-2022-0416 — Phase 2

   Jun 8, 2026
   Clinical update →

1. NCT00643877

   2008-46

   Phase 3 · active · other

   Colorectal Neoplasms

   CT.gov ↗
2. NCT00700440

   C225 (cetuximab)

   Phase 2 · completed · small_molecule

   Nasopharyngeal Carcinoma

   CT.gov ↗
3. NCT00862004

   VATS

   Phase 2 · active · other

   Non-small Cell Lung Cancer

   CT.gov ↗
4. NCT00993356

   Preoperative lanreotide treatment

   Phase 2 · active · small_molecule

   Acromegaly

   CT.gov ↗
5. NCT01019616

   paclitaxel/anthracycline

   Phase 3 · active · small_molecule

   Primary Breast Cancer

   CT.gov ↗
6. NCT01051362

   PLD and Carboplatin

   Phase 2 · active · small_molecule

   Non-small Cell Lung Cancer

   CT.gov ↗
7. NCT01054482

   Pre-operative chemotherapy

   Phase 2 · active · small_molecule

   Non-small Cell Lung Cancer

   CT.gov ↗
8. NCT01064999

   Oxaliplatin

   Phase 3 · active · small_molecule

   Rectal Cancer

   CT.gov ↗
9. NCT01143662

   Ypeginterferon alfa-2b

   Phase 3 · completed · small_molecule

   Chronic Hepatitis B

   CT.gov ↗
10. NCT01349517

    MIE

    Phase 2 · active · other

    Esophageal Cancer

    CT.gov ↗
11. NCT01368419

    Endostar

    Phase 2 · active · small_molecule

    Esophageal Cancer

    CT.gov ↗
12. NCT01410370

    Endostar

    Phase 2 · active · small_molecule

    Brain Metastases

    CT.gov ↗
13. NCT01471119

    Dermatophagoides Farinae Drops Group 1

    Phase 2 · completed · mab

    Atopic Dermatitis

    CT.gov ↗
14. NCT01496339

    MenSCs transplantation

    Phase 2 · active · mab

    Type 1 Diabetes Mellitus

    CT.gov ↗
15. NCT01512017

    Crystalline cellulose simple occlusive dressing

    Phase 3 · completed · other

    Split-thickness Skin Graft Donor Sites

    CT.gov ↗
16. NCT01540136

    Nedaplatin

    Phase 3 · completed · small_molecule

    Nasopharyngeal Carcinoma

    CT.gov ↗
17. NCT01558895

    Infrared ray heat treatment

    Phase 3 · active · other

    Liver Cirrhosis

    CT.gov ↗
18. NCT01616849

    cisplatin and 5-Fu combined with nimotuzumab

    Phase 2 · completed · small_molecule

    Stage IV Nasopharyngeal Carcinoma

    CT.gov ↗
19. NCT01637675

    20 mg sildenafil citrate by mouth

    Phase 3 · active · small_molecule

    Pulmonary Hypertension

    CT.gov ↗
20. NCT01665651

    Yougui granules

    Phase 2 · terminated · small_molecule

    Renal Insufficiency, Chronic

    CT.gov ↗
21. NCT01673789

    Stem Cell Educator

    Phase 2 · active · other

    Alopecia Areata

    CT.gov ↗
22. NCT01727193

    Azathioprine

    Phase 3 · completed · small_molecule

    Myasthenia Gravis

    CT.gov ↗
23. NCT01732380

    Raltitrexed

    Phase 2 · active · small_molecule

    Inoperable Esophageal Cancer Stage I-III

    CT.gov ↗
24. NCT01733589

    Recombinant human endostatin

    Phase 2 · completed · small_molecule

    Stage III Non-small-Cell Lung Cancer

    CT.gov ↗
25. NCT01760122

    Ypeginterferon alfa-2b

    Phase 3 · completed · small_molecule

    Chronic Hepatitis B

    CT.gov ↗
26. NCT01809392

    decitabine

    Phase 3 · active · small_molecule

    Acute Myelocytic Leukemia

    CT.gov ↗
27. NCT01818908

    DA-EPOCH

    Phase 2 · active · small_molecule

    NHL With Hemophagocytic Lymphohistiocytosis

    CT.gov ↗
28. NCT01872403

    nanoparticle albumin-bound paclitaxel/carboplatin

    Phase 2 · active · small_molecule

    Non-small Cell Lung Cancer

    CT.gov ↗
29. NCT02011997

    patients undergo cVATS segmentectomy

    Phase 3 · active · other

    Non-small Cell Lung Cancer Stage I

    CT.gov ↗
30. NCT02042690

    Chemotherapy

    Phase 3 · completed · small_molecule

    Acute Lymphoblastic Leukemia

    CT.gov ↗
31. NCT02095444

    Menstrual blood stem cells

    Phase 2 · active · small_molecule

    Acute Lung Injury

    CT.gov ↗
32. NCT02139501

    Recombinant Human Thrombopoietin (rhTPO)

    Phase 3 · completed · small_molecule

    Immune Thrombocytopenia

    CT.gov ↗
33. NCT02139579

    Bevacizumab

    Phase 2 · active · small_molecule

    Lung, Carcinoma

    CT.gov ↗
34. NCT02155764

    Octacalcium phosphate

    Phase 2 · completed · other

    Tooth Extraction

    CT.gov ↗
35. NCT02197481

    Clamp-Crushing technique

    Phase 3 · completed · other

    Hepatobiliary Disease

    CT.gov ↗
36. NCT02323022

    IAC regimen

    Phase 3 · completed · small_molecule

    Acute Myeloid Leukemia

    CT.gov ↗
37. NCT02332473

    Ypeginterferon alfa-2b

    Phase 3 · completed · small_molecule

    Chronic Hepatitis B

    CT.gov ↗
38. NCT02335879

    Gonal-F

    Phase 3 · completed · mab

    Anovulation

    CT.gov ↗
39. NCT02368587

    WJMSCs Vs. placebo

    Phase 2 · active · mab

    Ischemic Cardiomyopathy

    CT.gov ↗
40. NCT02375581

    Icotinib

    Phase 2 · active · small_molecule

    Esophageal Cancer

    CT.gov ↗
41. NCT02375620

    PEG-somatropin

    Phase 2 · active · mab

    Short Stature Children Born Small for Gestational Age (SGA)

    CT.gov ↗
42. NCT02408172

    Amlodipine

    Phase 3 · active · small_molecule

    Sleep Apnea Syndrome

    CT.gov ↗
43. NCT02423226

    Systemic chemotherapy (FOLFIRI)

    Phase 2 · completed · small_molecule

    Rectum Cancer

    CT.gov ↗
44. NCT02469792

    Liposuction

    Phase 2 · active · other

    Anterior Cruciate Ligament Partial Rupture

    CT.gov ↗
45. NCT02472431

    Intracavernosal administration of autologous ADRC

    Phase 2 · completed · other

    Erectile Dysfunction

    CT.gov ↗
46. NCT02474290

    Sorafenib

    Phase 3 · completed · small_molecule

    Acute Myeloid Leukemia

    CT.gov ↗
47. NCT02487563

    Decitabine

    Phase 3 · completed · small_molecule

    Thrombocytopenia

    CT.gov ↗
48. NCT02487693

    Cytokine-induced killer cells

    Phase 2 · active · mab

    Ovarian Carcinoma

    CT.gov ↗
49. NCT02491320

    Letrozole

    Phase 3 · completed · small_molecule

    Polycystic Ovary Syndrome

    CT.gov ↗
50. NCT02491333

    metformin

    Phase 3 · completed · small_molecule

    Polycystic Ovary Syndrome

    CT.gov ↗
51. NCT02491697

    DC-CIK Immunotherapy

    Phase 2 · active · mab

    Breast Cancer

    CT.gov ↗
52. NCT02494804

    Temozolomide

    Phase 2 · active · small_molecule

    Cytokine-Induced Killer Cells

    CT.gov ↗
53. NCT02498756

    Cytokine-induced killer cells

    Phase 2 · active · mab

    Melanoma

    CT.gov ↗
54. NCT02547350

    pharmorubicin or pirarubicin

    Phase 2 · active · small_molecule

    Upper Tract Urothelial Carcinoma

    CT.gov ↗
55. NCT02563340

    BM-MSCs

    Phase 2 · active · other

    Kidney Transplantation

    CT.gov ↗
56. NCT02563366

    BM-MSCs

    Phase 2 · active · other

    Kidney Transplantation

    CT.gov ↗
57. NCT02604615

    Capecitabine(Aibin)

    Phase 3 · active · small_molecule

    Stage III Esophageal Squamous Cell Carcinoma

    CT.gov ↗
58. NCT02621333

    CIK

    Phase 2 · terminated · mab

    Lung Adenocarcinoma

    CT.gov ↗
59. NCT02636231

    Endostatins

    Phase 2 · active · small_molecule

    Nasopharyngeal Carcinoma

    CT.gov ↗
60. NCT02644148

    Conventional Roux-en-Y Gastrojejunostomy

    Phase 2 · active · other

    Gastric Cancer

    CT.gov ↗
61. NCT02644408

    Megestrol（Yining）

    Phase 3 · completed · small_molecule

    Stage III Esophageal Squamous Cell Carcinoma

    CT.gov ↗
62. NCT02647255

    Methylprednisolone pulse

    Phase 3 · terminated · small_molecule

    Glomerulonephritis, IGA

    CT.gov ↗
63. NCT02656225

    Ejiao compound

    Phase 2 · active · small_molecule

    Postpartum Anemia

    CT.gov ↗
64. NCT02673008

    donor lymphocyte infusion

    Phase 3 · completed · mab

    Minimal Residual Disease

    CT.gov ↗
65. NCT02704767

    Apatinib

    Phase 2 · active · small_molecule

    Lung Cancer

    CT.gov ↗
66. NCT02740426

    Pirarubicin

    Phase 2 · active · small_molecule

    Upper Tract Urothelial Carcinoma

    CT.gov ↗
67. NCT02742727

    anti-CD7 CAR-pNK cells

    Phase 2 · active · mab

    Acute Myeloid Leukemia

    CT.gov ↗
68. NCT02748772

    Two Anti-angiogenesis Drugs（Endostar and Thalidomide）

    Phase 3 · active · small_molecule

    Colorectal Neoplasms

    CT.gov ↗
69. NCT02749526

    "Endostar"

    Phase 2 · terminated · small_molecule

    Esophageal

    CT.gov ↗
70. NCT02767674

    Rituximab

    Phase 3 · active · small_molecule

    Diffuse Large B-cell Lymphoma

    CT.gov ↗
71. NCT02782351

    CAR-T

    Phase 2 · active · mab

    Leukemia, Lymphocytic, Chronic, B-Cell

    CT.gov ↗
72. NCT02817204

    Aerobic Exercise

    Phase 3 · active · other

    Primary Hypertension

    CT.gov ↗
73. NCT02819583

    PCAR-019 (anti-CD19 CAR-T cells)

    Phase 2 · active · mab

    Acute Lymphocytic Leukemia

    CT.gov ↗
74. NCT02822053

    US-guided laser ablation for refractory neoplasms

    Phase 2 · active · other

    Refractory Neoplasms

    CT.gov ↗
75. NCT02839954

    anti-MUC1 CAR-pNK cells

    Phase 2 · active · mab

    Hepatocellular Carcinoma

    CT.gov ↗
76. NCT02844114

    Ganoderma lucidum spore

    Phase 2 · active · small_molecule

    Carcinoma, Non-Small-Cell Lung

    CT.gov ↗
77. NCT02844283

    Ad-HGF

    Phase 2 · active · small_molecule

    Myocardial Infarction

    CT.gov ↗
78. NCT02844881

    Apatinib

    Phase 2 · active · small_molecule

    Advanced Solid Tumors

    CT.gov ↗
79. NCT02858206

    Nimotuzumab

    Phase 2 · active · small_molecule

    Esophageal Neoplasms

    CT.gov ↗
80. NCT02878057

    Apatinib

    Phase 2 · completed · small_molecule

    Breast Cancer

    CT.gov ↗
81. NCT02889549

    ticagrelor

    Phase 3 · active · small_molecule

    Coronary Artery Disease

    CT.gov ↗
82. NCT02899169

    Realgar-Indigo naturalis formula

    Phase 3 · active · small_molecule

    Acute Promyelocytic Leukemia

    CT.gov ↗
83. NCT02907710

    Endostar

    Phase 3 · active · small_molecule

    Nasopharyngeal Carcinoma

    CT.gov ↗
84. NCT02942043

    Bevacizumab

    Phase 2 · active · small_molecule

    Malignant Pleural Effusion

    CT.gov ↗
85. NCT02971982

    rituximab /Dexamethasone/cyclophosphamide

    Phase 2 · active · small_molecule

    Treatment

    CT.gov ↗
86. NCT02976740

    Immunological Agent

    Phase 2 · active · small_molecule

    Lung Cancer Metastatic

    CT.gov ↗
87. NCT02985372

    Decitabine

    Phase 3 · active · small_molecule

    Acute Myeloid Leukemia, Adult

    CT.gov ↗
88. NCT03020979

    Apatinib

    Phase 2 · active · small_molecule

    Malignant Ascites

    CT.gov ↗
89. NCT03026452

    US-guided RFA

    Phase 2 · active · other

    Liver Cancer

    CT.gov ↗
90. NCT03046407

    retinal pigment epithelium transplantation

    Phase 2 · active · mab

    Dry Age-related Macular Degeneration

    CT.gov ↗
91. NCT03047772

    Atorvastatin

    Phase 2 · active · small_molecule

    Myocardial Infarction

    CT.gov ↗
92. NCT03071172

    Triptorelin for Injection

    Phase 3 · active · small_molecule

    Ovarian Hyperstimulation Syndrome

    CT.gov ↗
93. NCT03094351

    esophagectomy

    Phase 3 · active · other

    Esophageal Cancer

    CT.gov ↗
94. NCT03101514

    Kanglaite

    Phase 2 · completed · small_molecule

    Head and Neck Cancer

    CT.gov ↗
95. NCT03110341

    Erythropoietin

    Phase 3 · active · small_molecule

    Premature Infants

    CT.gov ↗
96. NCT03154749

    20170512

    Phase 2 · completed · small_molecule

    Triple-Negative Breast Cancer

    CT.gov ↗
97. NCT03156101

    BinD19

    Phase 2 · active · mab

    Relapsed B-cell Acute Lymphoblastic Leukemia

    CT.gov ↗
98. NCT03185611

    Rifaximin

    Phase 3 · active · small_molecule

    Crohn Disease

    CT.gov ↗
99. NCT03193424

    Apatinib

    Phase 2 · active · small_molecule

    Advanced Esophageal Squamous Carcinoma

    CT.gov ↗
100. NCT03219593

     Apatinib mesylate tablets

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
101. NCT03221088

     Jintrolong® low dose group

     Phase 2 · active · small_molecule

     Dwarfism

     CT.gov ↗
102. NCT03252925

     N-Acetylcysteine

     Phase 3 · completed · small_molecule

     Thrombotic Microangiopathies

     CT.gov ↗
103. NCT03255694

     PEG-somatropin

     Phase 2 · active · small_molecule

     Dwarfism

     CT.gov ↗
104. NCT03275493

     CD19 CAR-T cells

     Phase 2 · active · mab

     Acute Lymphoblastic Leukemia

     CT.gov ↗
105. NCT03331913

     Botulinum Toxin type A (intradermal / submucosal injection at pain area)

     Phase 3 · active · small_molecule

     Trigeminal Neuralgia

     CT.gov ↗
106. NCT03339583

     Zopiclone

     Phase 2 · completed · small_molecule

     Insomnia Chronic

     CT.gov ↗
107. NCT03366883

     Paclitaxel, Cisplatin Plus 5-FU (TCF)

     Phase 3 · active · other

     Esophageal Cancer Stage IIB

     CT.gov ↗
108. NCT03457662

     OMC and pseudo-SDT

     Phase 2 · completed · other

     Peripheral Arterial Disease

     CT.gov ↗
109. NCT03474926

     Routine Template-based lymphadenectomy

     Phase 2 · active · other

     Lymph Node Dissection

     CT.gov ↗
110. NCT03492515

     recombinant human thrombopoietin

     Phase 3 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
111. NCT03504657

     Drug-coated balloon angioplasty

     Phase 2 · active · other

     Vertebral Artery Stenosis

     CT.gov ↗
112. NCT03507244

     Pemetrexed

     Phase 2 · active · small_molecule

     Leptomeningeal Metastasis

     CT.gov ↗
113. NCT03521219

     Apatinib

     Phase 2 · active · small_molecule

     Intrahepatic Cholangiocarcinoma

     CT.gov ↗
114. NCT03525782

     CAR-T Cells

     Phase 2 · active · mab

     Lung Neoplasm Malignant

     CT.gov ↗
115. NCT03530085

     Decitabine

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
116. NCT03591471

     Glycosides Of Tripterygium Wilfordii Hook(GTW)

     Phase 2 · active · small_molecule

     Henoch-Schönlein Purpura Nephritis

     CT.gov ↗
117. NCT03609489

     Capecitabine

     Phase 2 · active · small_molecule

     Biliary Carcinoma

     CT.gov ↗
118. NCT03610321

     Gefarnate

     Phase 3 · active · small_molecule

     Coronary Artery Disease

     CT.gov ↗
119. NCT03613545

     probiotics, antibiotics or antidepressants

     Phase 3 · active · small_molecule

     Irritable Bowel Syndrome

     CT.gov ↗
120. NCT03624530

     Tyrosine kinase inhibitor (TKIs)

     Phase 3 · active · small_molecule

     Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

     CT.gov ↗
121. NCT03650738

     Apatinib

     Phase 2 · active · small_molecule

     Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer

     CT.gov ↗
122. NCT03665480

     G-SCF

     Phase 3 · active · small_molecule

     Granulocyte Colony-stimulating Factor

     CT.gov ↗
123. NCT03700333

     S-1 therapy

     Phase 3 · active · small_molecule

     Carcinoma, Non-Small-Cell Lung

     CT.gov ↗
124. NCT03728374

     Anlotinib

     Phase 2 · active · small_molecule

     Non-Small-Cell Lung Cancer

     CT.gov ↗
125. NCT03731442

     Paclitaxel

     Phase 3 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
126. NCT03733327

     Busulfan (BU)

     Phase 3 · active · small_molecule

     Primary Central Nervous System Lymphoma

     CT.gov ↗
127. NCT03736863

     Apatinib+ SHR-1210（Camrelizumab）

     Phase 2 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
128. NCT03758677

     Apatinib

     Phase 2 · active · small_molecule

     Non Small Cell Lung Cancer

     CT.gov ↗
129. NCT03764787

     Radiation+PD-1 Ab

     Phase 2 · active · other

     Proton Therapy

     CT.gov ↗
130. NCT03765190

     Radiation: Proton Therapy+PD-1 Ab

     Phase 2 · active · other

     Proton Therapy

     CT.gov ↗
131. NCT03765775

     Sintilimab

     Phase 2 · active · mab

     Carcinoma

     CT.gov ↗
132. NCT03766178

     Nimotuzumab + SHR-1210

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
133. NCT03817268

     Capecitabine monotherapy

     Phase 3 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
134. NCT03837808

     Nimotuzumab

     Phase 3 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
135. NCT03880695

     Anlotinib+ Liposomal Doxorubicin

     Phase 2 · active · small_molecule

     Sarcoma

     CT.gov ↗
136. NCT03919240

     CAR T-cell therapy

     Phase 2 · active · mab

     Acute Lymphoblastic Leukemia With Failed Remission

     CT.gov ↗
137. NCT03927495

     KN046

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
138. NCT03929107

     Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells

     Phase 2 · active · mab

     B Cell Lymphoma

     CT.gov ↗
139. NCT03931421

     CAR-T treatment

     Phase 2 · active · mab

     Multiple Myeloma

     CT.gov ↗
140. NCT03942185

     Oral Chinese Herbal Medicine of Clearing heat and Cooling blood therapy

     Phase 2 · active · small_molecule

     Psoriasis

     CT.gov ↗
141. NCT03946969

     Sintilimab

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
142. NCT03958097

     NK cell and PD-1 antibody

     Phase 2 · completed · other

     Non-small Cell Lung Cancer

     CT.gov ↗
143. NCT03961230

     Jueyin granules

     Phase 2 · active · small_molecule

     Psoriasis Vulgaris

     CT.gov ↗
144. NCT03967730

     Sonodynamic therapy(SDT)

     Phase 2 · terminated · other

     Peripheral Arterial Disease

     CT.gov ↗
145. NCT03975907

     CAR-BCMA T Cells

     Phase 2 · active · mab

     Multiple Myeloma

     CT.gov ↗
146. NCT03984968

     ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion

     Phase 2 · active · mab

     Acute Lymphoblastic Leukemia, Adult B-Cell

     CT.gov ↗
147. NCT03995732

     PC-SOD

     Phase 2 · active · small_molecule

     Myocardial Reperfusion Injury

     CT.gov ↗
148. NCT04026841

     PD-1 antibody Sintilimab

     Phase 2 · active · small_molecule

     Multiple Primary Lung Cancers

     CT.gov ↗
149. NCT04042597

     Anlotinib Hydrochloride

     Phase 2 · active · small_molecule

     Effect of Drugs

     CT.gov ↗
150. NCT04044651

     Lenvatinib

     Phase 3 · terminated · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
151. NCT04051840

     2019-SR-101

     Phase 1 · active · small_molecule

     Nutritional Supplement Toxicity

     CT.gov ↗
152. NCT04052152

     Anlotinib and Sintilimab injection

     Phase 2 · active · small_molecule

     Advanced Hepatocellular Carcinoma

     CT.gov ↗
153. NCT04053205

     Gentuximab

     Phase 2 · completed · small_molecule

     Advanced Gastric or Gastroesophageal Junction Cancer

     CT.gov ↗
154. NCT04072107

     sintilimab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
155. NCT04087967

     Decitabine plus HAAG regimen

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
156. NCT04160416

     Capecitabine-Oxaliplatin-Irinotecan Combination

     Phase 2 · active · small_molecule

     Unresectable Metastatic Colorectal Cancer

     CT.gov ↗
157. NCT04170530

     mFOLFOXIRI

     Phase 2 · active · small_molecule

     Locally Advanced Rectal Cancer

     CT.gov ↗
158. NCT04172259

     Doxorubicin liposome

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
159. NCT04180007

     Apatinib

     Phase 2 · active · small_molecule

     Thyroid

     CT.gov ↗
160. NCT04181489

     Sintilimab

     Phase 2 · active · small_molecule

     EBV-Positive DLBCL, Nos

     CT.gov ↗
161. NCT04183712

     gemcitabine and oxaliplatin.

     Phase 2 · active · small_molecule

     Gallbladder Carcinoma

     CT.gov ↗
162. NCT04189094

     Sintilimab

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer Limited Stage

     CT.gov ↗
163. NCT04196205

     Anti-CD19 CAR-T

     Phase 2 · active · mab

     Acute Lymphoblastic Leukemia ,Lymphomas

     CT.gov ↗
164. NCT04273581

     placebo

     Phase 2 · active · small_molecule

     COVID-19 Thalidomide

     CT.gov ↗
165. NCT04297202

     Apatinib Combined With SHR-1210 Injection

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
166. NCT04389151

     Toripalimab

     Phase 2 · active · small_molecule

     Locally Advanced Colon Cancer

     CT.gov ↗
167. NCT04397289

     Heparin and Rivaroxaban

     Phase 2 · completed · small_molecule

     Liver Cirrhosis

     CT.gov ↗
168. NCT04418648

     Toripalimab

     Phase 2 · terminated · small_molecule

     Small Cell Lung Cancer Limited Stage

     CT.gov ↗
169. NCT04423926

     Lenalidomide

     Phase 2 · active · small_molecule

     PTCL, NOS

     CT.gov ↗
170. NCT04425135

     Camrelizumab

     Phase 2 · active · small_molecule

     Lung Neoplasms

     CT.gov ↗
171. NCT04435197

     Pembrolizumab Injection

     Phase 2 · completed · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
172. NCT04438902

     osimertinib mesylate tablets and anlotinib hydrochloride capsules

     Phase 2 · terminated · small_molecule

     Non Small Cell Lung Cancer

     CT.gov ↗
173. NCT04440696

     Lanthanum Polystyrene Sulphonate Powder

     Phase 2 · active · small_molecule

     Hyperphosphatemia

     CT.gov ↗
174. NCT04465890

     ASC22

     Phase 2 · completed · small_molecule

     Chronic Hepatitis b

     CT.gov ↗
175. NCT04499365

     68Ga-DOTA/NOTA-FAPI-04

     Phase 1 · active · small_molecule

     Tumor

     CT.gov ↗
176. NCT04514835

     Cisplatin+Capecitabine+Sintilimab

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
177. NCT04515615

     Camrelizumab

     Phase 2 · active · small_molecule

     Gastric Cancer Stage III

     CT.gov ↗
178. NCT04517214

     Toripalimab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
179. NCT04525612

     68Ga-BNU-PSMA

     Phase 1 · active · other

     Tumor

     CT.gov ↗
180. NCT04533490

     SHR-1210

     Phase 2 · active · small_molecule

     Resectable Esophageal Squamous Cell Carcinoma

     CT.gov ↗
181. NCT04533828

     68Ga-FAPI-04

     Phase 1 · active · small_molecule

     Liver Fibrosis

     CT.gov ↗
182. NCT04543890

     Etoposide

     Phase 2 · active · small_molecule

     Small Cell Lung Cancer Limited Stage

     CT.gov ↗
183. NCT04547049

     Cytarabine

     Phase 3 · active · small_molecule

     Leukemia

     CT.gov ↗
184. NCT04570410

     Tislelizumab

     Phase 2 · completed · small_molecule

     Bladder Urothelial Carcinoma

     CT.gov ↗
185. NCT04572542

     Camrelizumab

     Phase 2 · active · small_molecule

     Locally Advanced or Metastatic Gastric Adenocarcinoma

     CT.gov ↗
186. NCT04611373

     Acetazolamide Levamisole

     Phase 3 · active · small_molecule

     HCC

     CT.gov ↗
187. NCT04622579

     lenalidomide combined with rituximab

     Phase 2 · active · small_molecule

     Diffuse Large B Cell Lymphoma

     CT.gov ↗
188. NCT04636593

     Almonertinib

     Phase 2 · active · small_molecule

     Non Small Cell Lung Cancer

     CT.gov ↗
189. NCT04643847

     Almonertinib

     Phase 2 · active · small_molecule

     EGFR Positive Non-small Cell Lung Cancer

     CT.gov ↗
190. NCT04683965

     Pemetrexed

     Phase 2 · active · small_molecule

     Colorectal Neoplasms

     CT.gov ↗
191. NCT04686929

     Abatacept s.c.

     Phase 2 · active · small_molecule

     Abatacept

     CT.gov ↗
192. NCT04690283

     Mimetic granules of Yiqi-Wenjing prescriptions

     Phase 3 · active · small_molecule

     Chemotherapy-induced Peripheral Neuropathy

     CT.gov ↗
193. NCT04693026

     Remdesivir

     Phase 3 · active · small_molecule

     Covid19

     CT.gov ↗
194. NCT04695925

     Osimertinib

     Phase 3 · active · small_molecule

     Non-small Cell Carcinoma

     CT.gov ↗
195. NCT04717531

     Pyrotinib

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
196. NCT04722952

     Visilizumab

     Phase 3 · active · small_molecule

     Immunotherapy

     CT.gov ↗
197. NCT04723875

     Paclitaxel or docetaxel + Cisplatin or carboplatin

     Phase 3 · active · small_molecule

     Uterine Cervical Neoplasms

     CT.gov ↗
198. NCT04735861

     Sintilimab

     Phase 2 · completed · small_molecule

     Ovarian Clear Cell Carcinoma

     CT.gov ↗
199. NCT04762485

     Humanized CD7 CAR-T cells

     Phase 2 · active · mab

     T Lymphoblastic Leukemia/Lymphoma

     CT.gov ↗
200. NCT04805736

     Camrelizumab

     Phase 2 · completed · small_molecule

     Breast Cancer

     CT.gov ↗
201. NCT04807673

     Pembrolizumab

     Phase 3 · active · mab

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
202. NCT04809181

     Azacitidine in Combination With Venetoclax

     Phase 2 · active · small_molecule

     Hematologic Malignancy

     CT.gov ↗
203. NCT04817527

     Edaravone Dexborneol

     Phase 2 · active · small_molecule

     Stroke, Ischemic

     CT.gov ↗
204. NCT04840758

     Sintilimab

     Phase 2 · active · small_molecule

     Multiple Primary Lung Cancer

     CT.gov ↗
205. NCT04848454

     Camrelizumab with vinorelbine and cisplatin

     Phase 2 · active · small_molecule

     HER2-negative Breast Cancer

     CT.gov ↗
206. NCT04849247

     68Ga-DOTA-FAPI, 177Lu-DOTA-FAPI

     Phase 1 · active · small_molecule

     177Lu-DOTA-FAPI

     CT.gov ↗
207. NCT04866836

     Radiotherapy

     Phase 2 · terminated · other

     Cholangiocarcinoma

     CT.gov ↗
208. NCT04884997

     toripalimab

     Phase 2 · active · small_molecule

     Malignant Melanoma

     CT.gov ↗
209. NCT04885647

     YPEG-rhEPO

     Phase 2 · completed · small_molecule

     Renal Anemia of Chronic Kidney Disease

     CT.gov ↗
210. NCT04888403

     Toripalimab+Nedaplatin+Albumin Paclitaxel

     Phase 2 · active · small_molecule

     Locally Advanced Esophageal Squamous Cell Carcinoma

     CT.gov ↗
211. NCT04906031

     Sodium stibogluconate

     Phase 2 · active · small_molecule

     Myelodysplastic Syndromes

     CT.gov ↗
212. NCT04910594

     recombinant human erythropoietin

     Phase 3 · active · small_molecule

     Lymphoma

     CT.gov ↗
213. NCT04926272

     18F-92

     Phase 2 · active · small_molecule

     Alzheimer's Disease

     CT.gov ↗
214. NCT04933669

     Imatinib

     Phase 2 · active · small_molecule

     Progression-free Survival

     CT.gov ↗
215. NCT04961515

     Orelabrutinib

     Phase 2 · active · small_molecule

     Primary Central Nervous System Hodgkin Lymphoma

     CT.gov ↗
216. NCT04963088

     BGB-A317

     Phase 2 · completed · small_molecule

     Gastric Cancer

     CT.gov ↗
217. NCT04979585

     Camrelizumab

     Phase 2 · active · small_molecule

     Melanoma

     CT.gov ↗
218. NCT04984018

     chidamide + camrelizumab

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
219. NCT05000554

     Neoadjuvant Therapy

     Phase 2 · active · other

     Gastric Cancer

     CT.gov ↗
220. NCT05004142

     FCN-437c+Fulvestrant

     Phase 2 · active · small_molecule

     Breast Neoplasms

     CT.gov ↗
221. NCT05007938

     Icotinib

     Phase 2 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
222. NCT05023707

     anti-FLT3 CAR-T

     Phase 2 · active · mab

     Acute Myeloid Leukemia

     CT.gov ↗
223. NCT05049681

     Camrelizumab

     Phase 3 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
224. NCT05062005

     Induction Chemotherapy

     Phase 3 · active · small_molecule

     Locally Advanced Nasopharyngeal Carcinoma

     CT.gov ↗
225. NCT05076786

     Chidamide

     Phase 2 · active · small_molecule

     Neuroendocrine Tumors

     CT.gov ↗
226. NCT05113355

     Chidamide

     Phase 2 · active · small_molecule

     Neuroendocrine Tumors

     CT.gov ↗
227. NCT05137171

     AK105 and anlotinib

     Phase 2 · active · small_molecule

     Cervical Cancer

     CT.gov ↗
228. NCT05170581

     Sintilimab Combined with Platinum-containing Chemotherapy

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
229. NCT05170594

     Bevacizumab

     Phase 2 · active · small_molecule

     Ovarian Cancer

     CT.gov ↗
230. NCT05183958

     Camrelizumab

     Phase 3 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
231. NCT05186545

     surufatinib + fulvestrant + chidamide

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
232. NCT05186558

     2021-SR-545

     Phase 2 · active · small_molecule

     Lymphoma, Large B-Cell, Diffuse

     CT.gov ↗
233. NCT05200312

     Zanubrutinib

     Phase 2 · active · small_molecule

     Non Hodgkin Lymphoma

     CT.gov ↗
234. NCT05237323

     mycophenolate mofetil 2 g per day

     Phase 3 · completed · small_molecule

     Lymphocytic Myocarditis (Disorder)

     CT.gov ↗
235. NCT05289908

     Pemetrexed (1)

     Phase 2 · completed · small_molecule

     Leptomeningeal Metastases

     CT.gov ↗
236. NCT05291052

     Tislelizumab

     Phase 2 · active · small_molecule

     Biliary Tract Tumor

     CT.gov ↗
237. NCT05292417

     sintilimab

     Phase 2 · active · small_molecule

     Colorectal Neoplasms

     CT.gov ↗
238. NCT05305885

     Pemetrexed

     Phase 2 · active · small_molecule

     Leptomeningeal Metastasis

     CT.gov ↗
239. NCT05315778

     autologous anti-BCMA chimeric antigen receptor T cells

     Phase 2 · active · mab

     ITP

     CT.gov ↗
240. NCT05322733

     Orelabrutinib

     Phase 2 · active · small_molecule

     Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

     CT.gov ↗
241. NCT05328804

     rhTPO

     Phase 3 · active · small_molecule

     Immune Thrombocytopenia

     CT.gov ↗
242. NCT05332587

     Rituximab

     Phase 3 · active · small_molecule

     Refractory Myasthenia Gravis

     CT.gov ↗
243. NCT05341193

     SYSUCC-CMY-2022-0416

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
244. NCT05350917

     Tislelizumab

     Phase 2 · active · small_molecule

     HER2-positive or Mutated Advanced Colorectal Cancer

     CT.gov ↗
245. NCT05355155

     Bevacizumab Biosimilar IBI305

     Phase 2 · active · small_molecule

     Post-orthotopic Liver Transplantation

     CT.gov ↗
246. NCT05364489

     Bevacizumab combined with Oxaliplatin and TAS-102

     Phase 2 · active · small_molecule

     Advanced Colorectal Cancer

     CT.gov ↗
247. NCT05376111

     Venetoclax, Azacitidine

     Phase 2 · active · small_molecule

     T-cell Acute Lymphoblastic Leukemia

     CT.gov ↗
248. NCT05381662

     CD19 CAR-T cells and CD19 positive feeder T cells

     Phase 2 · active · mab

     Acute Lymphoblastic Leukemia in Remission

     CT.gov ↗
249. NCT05413356

     Ruxolitinib

     Phase 2 · active · small_molecule

     Bronchiolitis Obliterans Syndrome

     CT.gov ↗
250. NCT05414461

     Combinations

     Phase 2 · completed · small_molecule

     Colorectal Cancer

     CT.gov ↗
251. NCT05428670

     Zanubrutinib+Rituximab+Lenalidomide

     Phase 2 · active · small_molecule

     Diffuse Large B Cell Lymphoma

     CT.gov ↗
252. NCT05430347

     Neoadjuvant therapy: TCbHPy

     Phase 2 · active · other

     Breast Cancer

     CT.gov ↗
253. NCT05433532

     Azacitidine

     Phase 2 · completed · small_molecule

     Philadelphia Chromosome

     CT.gov ↗
254. NCT05463809

     Continuous Gastrocnemius plane block with ropivacaine

     Phase 3 · active · small_molecule

     Foot Ankle Injuries

     CT.gov ↗
255. NCT05466201

     Eltrombopag 25 MG Oral Tablet

     Phase 3 · completed · small_molecule

     Stem Cell Transplant Complications

     CT.gov ↗
256. NCT05467852

     didroxyprogesterone

     Phase 3 · active · small_molecule

     Pregnancy Rate

     CT.gov ↗
257. NCT05491694

     Toripalimab

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
258. NCT05500937

     UDCA

     Phase 3 · active · small_molecule

     Diabetes Mellitus

     CT.gov ↗
259. NCT05506566

     68Ga-FAP-CHX

     Phase 2 · active · small_molecule

     Tumor

     CT.gov ↗
260. NCT05509478

     Lenvatinib

     Phase 2 · active · small_molecule

     Biliary Tract Cancer

     CT.gov ↗
261. NCT05513131

     Venetoclax；Azacitidine；Homoharringtonine

     Phase 2 · active · small_molecule

     Secondary Acute Myeloid Leukemia

     CT.gov ↗
262. NCT05520853

     SBRT combined with PD-1 inhibitors and thoracic hyperthermia

     Phase 2 · active · other

     Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC

     CT.gov ↗
263. NCT05521204

     Olverembatinib

     Phase 2 · active · small_molecule

     Myeloproliferative Neoplasm

     CT.gov ↗
264. NCT05522192

     Mitoxantrone liposome

     Phase 2 · active · small_molecule

     Relapsed or Refractory Acute Myeloid Leukemia

     CT.gov ↗
265. NCT05522582

     Methotrexate tablets

     Phase 2 · active · small_molecule

     Solid Tumors

     CT.gov ↗
266. NCT05524168

     Camrelizumab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma

     CT.gov ↗
267. NCT05524389

     Chemotherapy

     Phase 3 · active · small_molecule

     Endometrial Cancer

     CT.gov ↗
268. NCT05539235

     different degrees of adjustment of the injection interval

     Phase 3 · active · small_molecule

     Exudative Age-Related Macular Degeneration

     CT.gov ↗
269. NCT05547828

     Tislelizumab combined with chemoradiotherapy

     Phase 2 · active · small_molecule

     ESCC

     CT.gov ↗
270. NCT05559450

     Blinatumomab

     Phase 2 · active · small_molecule

     B-cell Acute Lymphoblastic Leukemia

     CT.gov ↗
271. NCT05584761

     unrelated umbilical cord blood

     Phase 2 · active · small_molecule

     Myelodysplastic Syndromes

     CT.gov ↗
272. NCT05629806

     Metformin plus pioglitazone

     Phase 3 · active · small_molecule

     Type 2 Diabetes

     CT.gov ↗
273. NCT05654194

     Azacitidine Combined With Venetoclax and ATRA group

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
274. NCT05659056

     NJMU-BC01

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
275. NCT05669079

     decitabine

     Phase 3 · active · small_molecule

     Poor Graft Function

     CT.gov ↗
276. NCT05681390

     Tislelizumab

     Phase 2 · active · small_molecule

     Pancreatic Neoplasms

     CT.gov ↗
277. NCT05715931

     Toripalimab

     Phase 2 · active · small_molecule

     Adenocarcinoma of the Stomach

     CT.gov ↗
278. NCT05732662

     Cadonilimab

     Phase 2 · active · small_molecule

     Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

     CT.gov ↗
279. NCT05737303

     nab-paclitaxel combined with carboplatin

     Phase 3 · active · small_molecule

     Epithelial Ovarian Carcinoma Stage III

     CT.gov ↗
280. NCT05754736

     Ametinib combined with bevacizumab

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
281. NCT05771402

     Anti-PD-1 antibody

     Phase 2 · active · small_molecule

     Chronic Hepatitis b

     CT.gov ↗
282. NCT05774028

     2023-SR-002

     Phase 2 · active · small_molecule

     NK-T-Cell Lymphoma, Extranodal

     CT.gov ↗
283. NCT05777278

     Savolitinib

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
284. NCT05777369

     Rituximab

     Phase 3 · active · small_molecule

     Diffuse Large B-cell Lymphoma

     CT.gov ↗
285. NCT05784974

     Cadonilimab

     Phase 2 · active · small_molecule

     Lung Cancer

     CT.gov ↗
286. NCT05794425

     Cyclosporine A

     Phase 2 · active · small_molecule

     Bone Marrow Failure Disorders

     CT.gov ↗
287. NCT05805098

     Venetoclax

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
288. NCT05808582

     chidamide，fulvestrant

     Phase 2 · active · small_molecule

     Hormone Receptor-positive Advanced Breast Cancer

     CT.gov ↗
289. NCT05809167

     VEN+AZA+Modified BUCY

     Phase 2 · active · small_molecule

     Allogeneic Hematopoietic Stem Cell Transplantation

     CT.gov ↗
290. NCT05809180

     Rituximab

     Phase 3 · active · small_molecule

     Diffuse Large B-cell Lymphoma

     CT.gov ↗
291. NCT05811676

     Tranexamic acid

     Phase 3 · completed · small_molecule

     Hemorrhage, Postpartum

     CT.gov ↗
292. NCT05812430

     anlotinib+TQB2450+nab-paclitaxel+cisplatin

     Phase 2 · active · small_molecule

     Advanced Biliary Tract Cancer

     CT.gov ↗
293. NCT05814640

     Fluoxetine

     Phase 2 · active · small_molecule

     Depression

     CT.gov ↗
294. NCT05817955

     Azacitidine (AZA) with Ruxolitinib

     Phase 2 · active · small_molecule

     MDS/MPN

     CT.gov ↗
295. NCT05823623

     Inetetamab

     Phase 2 · active · small_molecule

     Breast Cancer

     CT.gov ↗
296. NCT05823714

     VEN+AZA+Modified BUCY

     Phase 2 · active · small_molecule

     Allogeneic Hematopoietic Stem Cell Transplantation

     CT.gov ↗
297. NCT05860868

     2 cycles induction chemotherapy

     Phase 3 · active · small_molecule

     Locally Advanced Nasopharyngeal Carcinoma

     CT.gov ↗
298. NCT05871099

     Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

     Phase 3 · active · other

     Gastric Cancer

     CT.gov ↗
299. NCT05896787

     L2023-K003-002

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
300. NCT05900921

     Trilaciclib

     Phase 2 · active · small_molecule

     Advanced Squamous Non-Small-Cell Lung Cancer

     CT.gov ↗
301. NCT05901584

     Cadonilimab

     Phase 2 · active · small_molecule

     Immunotherapy

     CT.gov ↗
302. NCT05901974

     Venetoclax

     Phase 2 · active · small_molecule

     Acute Leukemia of Ambiguous Lineage

     CT.gov ↗
303. NCT05917379

     fecal microbiota

     Phase 2 · completed · mab

     Insomnia Chronic

     CT.gov ↗
304. NCT05929248

     Telitacicept

     Phase 2 · active · small_molecule

     Systemic Lupus Erythematosus

     CT.gov ↗
305. NCT05931757

     Olverembatinib

     Phase 2 · active · small_molecule

     Philadelphia-Positive ALL

     CT.gov ↗
306. NCT05946460

     Aumolertinib

     Phase 2 · active · small_molecule

     Lung Cancer

     CT.gov ↗
307. NCT05951855

     Selinexor

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia (Relapsed/Refractory)

     CT.gov ↗
308. NCT05956639

     6-month course of antiandrogen drugs

     Phase 3 · active · small_molecule

     Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

     CT.gov ↗
309. NCT05963386

     177Lu-DOTA-EB-FAPI radionuclide therapy

     Phase 2 · completed · small_molecule

     Refractory Solid Tumor

     CT.gov ↗
310. NCT05964101

     Nivolumab Injection [Opdivo]

     Phase 2 · active · small_molecule

     Neoplasms

     CT.gov ↗
311. NCT05970666

     TACE with adebrelimab and bevacizumab

     Phase 2 · active · small_molecule

     Adebrelimab

     CT.gov ↗
312. NCT05990998

     68Ga-DOTATATE and 68Ga-FAPI

     Phase 2 · completed · small_molecule

     Tumor Positron-Emission Tomography

     CT.gov ↗
313. NCT05998902

     Trophic enteral feeding combined with supplemental parenteral nutrition

     Phase 3 · active · other

     Severe Stroke

     CT.gov ↗
314. NCT06017583

     Tislelizumab

     Phase 3 · active · small_molecule

     Rectal Neoplasms

     CT.gov ↗
315. NCT06028633

     pembrolizumab

     Phase 2 · active · small_molecule

     Advanced Non-squamous Non-small-cell Lung Cancer

     CT.gov ↗
316. NCT06029036

     Darolutamide+ADT

     Phase 2 · active · small_molecule

     Prostate Cancer

     CT.gov ↗
317. NCT06037655

     Total Neoadjuvant Treatment

     Phase 2 · active · small_molecule

     Biliary Tract Neoplasms

     CT.gov ↗
318. NCT06041477

     SL-B2022-793-01

     Phase 3 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
319. NCT06060704

     Envafolimab

     Phase 2 · active · small_molecule

     Metastatic Colorectal Cancer

     CT.gov ↗
320. NCT06061146

     Arm A

     Phase 2 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
321. NCT06071052

     TACE and HAIC Combined With Regorafenib

     Phase 2 · completed · other

     Liver Metastasis Colon Cancer

     CT.gov ↗
322. NCT06078306

     Azacitidine Injection

     Phase 2 · active · small_molecule

     B Acute Lymphoblastic Leukemia

     CT.gov ↗
323. NCT06080256

     Alirocumab

     Phase 3 · active · small_molecule

     Intracranial Atherosclerosis

     CT.gov ↗
324. NCT06080854

     Toripalimab

     Phase 2 · active · small_molecule

     Pancreatic Carcinoma

     CT.gov ↗
325. NCT06091423

     XELOX combined with Fruquintinib and Sintilimab

     Phase 2 · active · small_molecule

     Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

     CT.gov ↗
326. NCT06092242

     Tas-102(Suyuan) combined with bevacizumab

     Phase 2 · active · small_molecule

     Colorectal Cancer

     CT.gov ↗
327. NCT06102824

     Organoid-guided treatment

     Phase 2 · active · small_molecule

     HER2-negative Breast Cancer

     CT.gov ↗
328. NCT06108596

     Sintilimab with Interleukin-2+CAPOX

     Phase 2 · completed · small_molecule

     Locally Advanced Rectal Adenocarcinoma

     CT.gov ↗
329. NCT06141096

     MB07133

     Phase 2 · active · small_molecule

     Safety Issues

     CT.gov ↗
330. NCT06141304

     Plerixafor

     Phase 2 · active · small_molecule

     Relapsed Adult ALL

     CT.gov ↗
331. NCT06151080

     Lenalidomide combined with G-CHOP (LO CHOP)

     Phase 2 · active · small_molecule

     DLBCL - Diffuse Large B Cell Lymphoma

     CT.gov ↗
332. NCT06151106

     Chidamide combined with Duvillisib

     Phase 2 · active · small_molecule

     Peripheral T Cell Lymphoma

     CT.gov ↗
333. NCT06158412

     All-trans Retinoic Acid in combination with the KPD Regimen

     Phase 2 · active · small_molecule

     Multiple Myeloma in Relapse

     CT.gov ↗
334. NCT06217003

     Trilaciclib

     Phase 2 · active · small_molecule

     Osteosarcoma

     CT.gov ↗
335. NCT06231680

     Camrelizumab

     Phase 2 · active · small_molecule

     Lung Cancer, Nonsmall Cell

     CT.gov ↗
336. NCT06241469

     Sintilimab,nab-paclitaxel and tegio

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
337. NCT06254521

     Tislelizumab combined with chemotherapy

     Phase 2 · active · small_molecule

     Rectal Cancer

     CT.gov ↗
338. NCT06279754

     Recombinant Human Endostatin Injection

     Phase 2 · active · small_molecule

     Locally Advanced Squamous Non-small Cell Lung Cancer

     CT.gov ↗
339. NCT06281561

     Normal Saline

     Phase 3 · active · small_molecule

     Postoperative Sleep Disturbance

     CT.gov ↗
340. NCT06301828

     Envafolimab Injection

     Phase 2 · active · small_molecule

     Gastrointestinal Neoplasms

     CT.gov ↗
341. NCT06316856

     Autologous CD5 CAR T-cells

     Phase 2 · active · small_molecule

     T-Cell Acute Lymphocytic Leukemia

     CT.gov ↗
342. NCT06341530

     anlotinib combined with penpulimab

     Phase 2 · active · small_molecule

     Non-small Cell Lung Cancer

     CT.gov ↗
343. NCT06341894

     Dalpiciclib

     Phase 2 · active · small_molecule

     Early Breast Cancer

     CT.gov ↗
344. NCT06345365

     09

     Phase 3 · active · small_molecule

     Acute Myeloid Leukaemia

     CT.gov ↗
345. NCT06356688

     13914704178

     Phase 2 · active · small_molecule

     Locally Advanced Esophageal Squamous Cell Carcinoma

     CT.gov ↗
346. NCT06360458

     Methylprednisolone sodium succinate

     Phase 3 · active · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
347. NCT06367114

     ssCART-19

     Phase 2 · active · mab

     Relapsed or Refractory Acute Lymphoblastic Leukemia

     CT.gov ↗
348. NCT06385847

     Zoladex

     Phase 2 · active · small_molecule

     Prostate Cancer

     CT.gov ↗
349. NCT06392971

     Deep-sea fish oil

     Phase 2 · active · small_molecule

     Radiation Toxicity

     CT.gov ↗
350. NCT06394128

     Cangpo Liujun Prescription

     Phase 2 · active · small_molecule

     Cancer-Related Fatigue

     CT.gov ↗
351. NCT06394674

     Furmonertinib

     Phase 2 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
352. NCT06411743

     Recombinant Human Albumin Injection

     Phase 3 · completed · mab

     Hepatic Ascites

     CT.gov ↗
353. NCT06418945

     Tinidazole oral microneedle patch

     Phase 3 · active · other

     Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis

     CT.gov ↗
354. NCT06434662

     mitoxantrone hydrochloride liposome

     Phase 2 · active · small_molecule

     Relapsed/Refractory Acute Myeloid Leukaemia

     CT.gov ↗
355. NCT06439550

     Serplulimab

     Phase 2 · active · small_molecule

     HER2-positive Gastric Cancer

     CT.gov ↗
356. NCT06446206

     2024-HS-022

     Phase 2 · active · small_molecule

     Platinum-sensitive Relapsed Ovarian Cancer

     CT.gov ↗
357. NCT06461910

     Serplulimab

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
358. NCT06467565

     Liposomal irinotecan

     Phase 2 · active · small_molecule

     Pancreatic Ductal Adenocarcinoma

     CT.gov ↗
359. NCT06485713

     trifluridine/tipiracil combined with fufuquitinib

     Phase 2 · active · small_molecule

     Metastatic Colorectal Cancer

     CT.gov ↗
360. NCT06486337

     CMOP±R

     Phase 2 · active · small_molecule

     NHL

     CT.gov ↗
361. NCT06492317

     Disitamab Vedotin

     Phase 2 · active · small_molecule

     HER2-positive Gastric Cancer

     CT.gov ↗
362. NCT06498154

     Neoadjuvant Chemotherapy combined with Neoadjuvant Radiotherapy

     Phase 2 · active · other

     Breast Cancer

     CT.gov ↗
363. NCT06520163

     Etoposide

     Phase 3 · active · small_molecule

     Non-Hodgkin's Lymphoma

     CT.gov ↗
364. NCT06520176

     Etoposide

     Phase 3 · active · small_molecule

     Multiple Myeloma

     CT.gov ↗
365. NCT06531161

     Suxiao Jiuxin Pill

     Phase 3 · active · small_molecule

     Acute Mountain Sickness

     CT.gov ↗
366. NCT06532552

     VACl

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia, Adult

     CT.gov ↗
367. NCT06544109

     venetoclax

     Phase 3 · active · small_molecule

     Acute Promyelocytic Leukemia

     CT.gov ↗
368. NCT06554626

     Dexamethasone

     Phase 2 · active · small_molecule

     Precursor B-Cell Lymphoblastic Leukemia

     CT.gov ↗
369. NCT06562166

     online adaptive radiotherapy

     Phase 2 · active · other

     Cervical Cancer

     CT.gov ↗
370. NCT06564493

     Cyclophosphamide

     Phase 2 · active · small_molecule

     Acute Lymphoblastic Leukemia, Pediatric

     CT.gov ↗
371. NCT06574412

     cardonilizumab combined with renvastinib

     Phase 2 · active · small_molecule

     Resectable Clear Cell Carcinoma of the Kidney

     CT.gov ↗
372. NCT06584006

     XMDYYYXYK-12

     Phase 2 · active · small_molecule

     Hematological Malignancy

     CT.gov ↗
373. NCT06592170

     Linperlisib combination with obinutuzumab

     Phase 2 · active · small_molecule

     Lymphoma

     CT.gov ↗
374. NCT06612580

     68Ga-AAZTA-NI-093

     Phase 1 · active · small_molecule

     Prostate Cancer (Adenocarcinoma)

     CT.gov ↗
375. NCT06613269

     68Ga-NY104 PET/CT

     Phase 2 · active · small_molecule

     Clear Cell Renal Cell Carcinoma

     CT.gov ↗
376. NCT06621212

     mitoxantrone hydrochloride liposome

     Phase 2 · active · small_molecule

     Relapsed/Refractory Acute Myeloid Leukaemia

     CT.gov ↗
377. NCT06657391

     recombinant humanized anti-CD25 monoclonal antibody

     Phase 2 · active · small_molecule

     Transfusion Dependent Thalassemia

     CT.gov ↗
378. NCT06663943

     CM313 (SC)

     Phase 2 · active · small_molecule

     Pemphigus Disease

     CT.gov ↗
379. NCT06676722

     SBRT combined with Nimotuzumab followed by Tislelizumab

     Phase 2 · active · small_molecule

     Nasopharyngeal Cancinoma (NPC)

     CT.gov ↗
380. NCT06680115

     Sintilimab

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma (NPC)

     CT.gov ↗
381. NCT06682130

     Group A：Patients with PR or ctDNA positivity after salvage treatment

     Phase 2 · active · small_molecule

     Diffuse Large B-cell Lymphoma(DLBCL)

     CT.gov ↗
382. NCT06696742

     Clostridium Butyricum Tablets

     Phase 2 · active · small_molecule

     Bladder (Urothelial, Transitional Cell) Cancer

     CT.gov ↗
383. NCT06717113

     18F-FDG

     Phase 1 · active · small_molecule

     Multiple Myeloma and Malignant Plasma Cell Neoplasms

     CT.gov ↗
384. NCT06734572

     18F-FAPIBiotin

     Phase 1 · active · small_molecule

     Malignant Neoplasm

     CT.gov ↗
385. NCT06737705

     Baritinib

     Phase 2 · completed · small_molecule

     Intracerebral Hemorrhage

     CT.gov ↗
386. NCT06737913

     intravenous infusion (IV) of Adebrelimab (ADE)

     Phase 2 · active · small_molecule

     Advanced Hepatocellular Carcinoma (HCC)

     CT.gov ↗
387. NCT06742515

     Blinatumomab plus Reduced-dose Chemotherapy

     Phase 2 · active · small_molecule

     Precursor B-Cell Acute Lymphoblastic Leukemia

     CT.gov ↗
388. NCT06746961

     QL1706 (bispecific antibody targeting PD-1 and CLTA-4)

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma (ESCC)

     CT.gov ↗
389. NCT06751849

     PD-1 inhibitor

     Phase 2 · active · small_molecule

     Advanced NSCLC

     CT.gov ↗
390. NCT06754267

     Venetoclax

     Phase 2 · active · small_molecule

     Precursor B-Cell Acute Lymphoblastic Leukemia

     CT.gov ↗
391. NCT06760065

     Keverprazan Hydrochloride tablets + high dose amoxicillin

     Phase 3 · active · small_molecule

     Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education

     CT.gov ↗
392. NCT06762327

     Ensartinib

     Phase 2 · active · small_molecule

     Solid Tumors

     CT.gov ↗
393. NCT06762782

     Postoperative adjuvant lenvatinib

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
394. NCT06766019

     PC-IIT-003

     Phase 2 · active · small_molecule

     Pancreatic Cancer

     CT.gov ↗
395. NCT06775275

     Adebellizumab

     Phase 2 · active · small_molecule

     Resectable Lung Non-Small Cell Carcinoma

     CT.gov ↗
396. NCT06791083

     Envafolimab

     Phase 2 · active · small_molecule

     Gastric Cancer

     CT.gov ↗
397. NCT06802835

     EGFR Antibody

     Phase 2 · active · small_molecule

     Nasopharyngeal Cancinoma (NPC)

     CT.gov ↗
398. NCT06810791

     HVA

     Phase 3 · active · small_molecule

     Newly Diagnosed Acute Myeloid Leukemia With High Risk

     CT.gov ↗
399. NCT06816134

     TmBU conditioning Regimen

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
400. NCT06827899

     XMDYYYXYK-04

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
401. NCT06832904

     pyrotinib and trastuzumab in combinition with neoadjuvant chemotherapy

     Phase 2 · active · small_molecule

     HER2-positive Breast Cancer

     CT.gov ↗
402. NCT06838910

     Experimental: tislelizumab+anlotinib

     Phase 2 · active · small_molecule

     Thymic Carcinoma

     CT.gov ↗
403. NCT06861348

     Inotuzumab Ozogamicin±Donor Lymphocyte Infusion

     Phase 2 · active · small_molecule

     Leukemia, Lymphocytic, Acute

     CT.gov ↗
404. NCT06864013

     Experimental

     Phase 2 · active · small_molecule

     Locally Advanced Rectal Cancer (LARC)

     CT.gov ↗
405. NCT06875076

     Ivonescimab Combined With Chemotherapy

     Phase 2 · active · small_molecule

     Pretreated Pleural Mesothelioma

     CT.gov ↗
406. NCT06900010

     CM336 Injection

     Phase 2 · active · mab

     Autoimmune Bullous Disease

     CT.gov ↗
407. NCT06905522

     Bedaquiline (B)

     Phase 3 · active · small_molecule

     Pulmonary Tuberculosis

     CT.gov ↗
408. NCT06911554

     Recombinant Human Albumin Injection

     Phase 3 · completed · mab

     Hepatic Ascites

     CT.gov ↗
409. NCT06926790

     Nivolumab & Ipilimumab

     Phase 2 · active · small_molecule

     Lung Cancer - Non Small Cell

     CT.gov ↗
410. NCT06939439

     Tislelizumab + SOX Chemotherapy

     Phase 3 · active · small_molecule

     Gastric Cancer Stage III

     CT.gov ↗
411. NCT06939452

     anlotinib +TQB2450 + Oxaliplatin+S-1

     Phase 2 · active · small_molecule

     Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

     CT.gov ↗
412. NCT06949982

     experimental group x-MAP

     Phase 2 · active · other

     Metastatic Colorectal Cancer (mCRC)

     CT.gov ↗
413. NCT06968806

     Ketorolac

     Phase 3 · active · small_molecule

     Aortic Dissection

     CT.gov ↗
414. NCT06982755

     compound diclofenac sodium

     Phase 2 · active · small_molecule

     Acute Abdominal Pain

     CT.gov ↗
415. NCT06985498

     Sandwich stratergy

     Phase 2 · active · other

     Acute Lymphobkastic Leukemia

     CT.gov ↗
416. NCT06988956

     Nimotuzumab

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
417. NCT06990321

     Intermediate-dose Cytarabine in Combination with Venetoclax

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia (AML)

     CT.gov ↗
418. NCT06992739

     Trilaciclib and Sacituzumab Tirumotecan

     Phase 2 · active · small_molecule

     NSCLC (Advanced Non-small Cell Lung Cancer)

     CT.gov ↗
419. NCT06999148

     Radiotherapy plus temozolomide

     Phase 2 · active · small_molecule

     Glioma (Any Grade) in the Brain

     CT.gov ↗
420. NCT07003464

     Zanubrutinib

     Phase 2 · active · small_molecule

     Chronic Lymphocytic Leukemia

     CT.gov ↗
421. NCT07007949

     Ivosidenib combined with venetoclax and azacitidine

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
422. NCT07012447

     Venetoclax

     Phase 2 · active · small_molecule

     Early T Acute Lymphoblastic Leukemia

     CT.gov ↗
423. NCT07015489

     induction chemotherapy and immunotherapy

     Phase 2 · completed · small_molecule

     ESCC

     CT.gov ↗
424. NCT07016724

     cadonilizumab combined with neoadjuvant radiochemotherapy

     Phase 2 · active · other

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
425. NCT07022223

     orelabrutinib combined with rituximab regimen

     Phase 2 · active · small_molecule

     Marginal Zone Lymphoma(MZL)

     CT.gov ↗
426. NCT07025174

     PD-1/CTLA-4 Dual Functional Antibody

     Phase 2 · active · small_molecule

     Bile Duct Carcinoma

     CT.gov ↗
427. NCT07028073

     Group A (FIT): Avapritinib + IA regimen

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia With T(8;21)(Q22;Q22)

     CT.gov ↗
428. NCT07034950

     Intravenous esketamine using Dixon's up-and-down sequential method

     Phase 2 · active · small_molecule

     Hepatic Neoplasm

     CT.gov ↗
429. NCT07034963

     Determine the ED50 and ED95 of esketamine

     Phase 2 · active · small_molecule

     Intrauterine Polyp

     CT.gov ↗
430. NCT07035808

     QL1706-2025-086

     Phase 2 · active · other

     Cervical Cancer Stage IVA

     CT.gov ↗
431. NCT07047183

     VEN (Venetoclax)

     Phase 2 · active · small_molecule

     Myelodysplastic Neoplasms

     CT.gov ↗
432. NCT07053761

     2025-206

     Phase 2 · active · small_molecule

     Radiation - Induced Proctitis

     CT.gov ↗
433. NCT07117760

     225Ac-LNC1011

     Phase 2 · active · small_molecule

     Prostate Cancer

     CT.gov ↗
434. NCT07128693

     Sacituzumab Tirumotecan in combination with tislelizumab

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma

     CT.gov ↗
435. NCT07131501

     Iparomlimab and Tuvonralimab Injection (QL1706)

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma

     CT.gov ↗
436. NCT07134101

     Serplulimab

     Phase 2 · active · small_molecule

     Colorectal Cancer (Diagnosis)

     CT.gov ↗
437. NCT07137039

     Adebrelimab+Albumin paclitaxel +Cisplatin

     Phase 2 · active · small_molecule

     Locally Advanced Hypopharyngeal Cancer

     CT.gov ↗
438. NCT07141303

     The methylprednisolone sodium succinate

     Phase 3 · active · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
439. NCT07142421

     Combination therapy (COMB)

     Phase 2 · active · small_molecule

     Esophageal Squamous Cell Carcinoma (ESCC)

     CT.gov ↗
440. NCT07150377

     First-line Cohort

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
441. NCT07151209

     Iparomlimab and Tuvonralimab combined with lenvatinib and SOX

     Phase 2 · active · small_molecule

     Gastric or Gastroesophageal Junction Adenocarcinoma

     CT.gov ↗
442. NCT07155265

     Remimazolam Besylate

     Phase 3 · active · small_molecule

     Critical Illness; Mechanical Ventilation; Shock

     CT.gov ↗
443. NCT07159620

     VEN (Venetoclax)

     Phase 2 · active · small_molecule

     Adult T-cell Leukemia/Lymphoma

     CT.gov ↗
444. NCT07161115

     Immunotherapy combined with chemotherapy

     Phase 2 · active · small_molecule

     Rectal Adenocarcinoma

     CT.gov ↗
445. NCT07162298

     Dragon Boat Training

     Phase 2 · active · other

     Breast Cancer

     CT.gov ↗
446. NCT07174947

     Fluoxetine (drug)

     Phase 2 · active · small_molecule

     Hepatobiliary Malignancy

     CT.gov ↗
447. NCT07177118

     Ustekinumab

     Phase 3 · active · small_molecule

     Crohn Disease

     CT.gov ↗
448. NCT07179120

     Semaglutide (Rybelsus®)

     Phase 2 · active · small_molecule

     Obesity-related Male Infertility

     CT.gov ↗
449. NCT07189793

     Toripalimab

     Phase 2 · active · small_molecule

     Urinary Bladder Neoplasms

     CT.gov ↗
450. NCT07190027

     Arm 1： Standard Synchronous Group

     Phase 2 · active · small_molecule

     Advanced Non-Small Cell Lung Cancer (NSCLC)

     CT.gov ↗
451. NCT07199504

     Dipyridamole 50mg tid

     Phase 3 · active · small_molecule

     Restless Leg Syndrome Due to Uraemia

     CT.gov ↗
452. NCT07236151

     Apheresis and Bridging Therapy

     Phase 2 · completed · other

     Large B-cell Lymphoma

     CT.gov ↗
453. NCT07240987

     0.9% sodium chloride

     Phase 2 · active · small_molecule

     Kidney Disease, Chronic

     CT.gov ↗
454. NCT07254858

     Neoadjuvant Chemotherapy (NACT)

     Phase 2 · active · small_molecule

     HR+/HER2- Breast Cancer

     CT.gov ↗
455. NCT07259707

     GVA + HDAC Consolidation & Gilteritinib Maintenance

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
456. NCT07263425

     Ommaya 02

     Phase 2 · active · small_molecule

     Leptomeningeal Metastasis of HER2-positive Breast Cancer

     CT.gov ↗
457. NCT07263607

     DMTs + taurine

     Phase 2 · active · small_molecule

     Multiple Sclerosis (MS) Relapsing Remitting

     CT.gov ↗
458. NCT07277439

     Radiochemoimmunotherapy

     Phase 2 · active · other

     Gastric Cancer

     CT.gov ↗
459. NCT07279610

     N-Acetylcysteine (NAC) Treatment

     Phase 3 · active · small_molecule

     Thrombotic Microangiopathy

     CT.gov ↗
460. NCT07281976

     LBL-024 for Injection

     Phase 2 · active · small_molecule

     Triple Negative Breast Cancer

     CT.gov ↗
461. NCT07289178

     Serratus Plane block (single injection)

     Phase 2 · active · other

     Serratus Plane Block

     CT.gov ↗
462. NCT07299123

     3D hypoxia-preconditioned UC-MSC group

     Phase 2 · active · small_molecule

     Severe Aplastic Anemia (SAA)

     CT.gov ↗
463. NCT07303283

     Becotatug Vedotin

     Phase 2 · active · small_molecule

     Nasopharyngeal Carcinoma (NPC)

     CT.gov ↗
464. NCT07303881

     golidocitinib

     Phase 2 · active · small_molecule

     IrAE

     CT.gov ↗
465. NCT07307586

     AZVUDINE

     Phase 3 · active · small_molecule

     Chronic Hepatitis B

     CT.gov ↗
466. NCT07315035

     QL1706 (Iparomlimab/Tuvonralimab)

     Phase 2 · active · small_molecule

     Gastric Cancer Stage III

     CT.gov ↗
467. NCT07331454

     Robotic Gastrectomy

     Phase 3 · active · other

     Gastric Cancer (GC)

     CT.gov ↗
468. NCT07337564

     SHR-1139 Injection

     Phase 2 · active · small_molecule

     Pyoderma Gangrenosum

     CT.gov ↗
469. NCT07338344

     Luspatercept combined with low-dose thalidomide

     Phase 2 · active · small_molecule

     Transfusion-dependent β-thalassemia Patients

     CT.gov ↗
470. NCT07361991

     IBI363

     Phase 2 · active · small_molecule

     Advan'ce'd

     CT.gov ↗
471. NCT07363382

     68Ga-G21

     Phase 2 · active · small_molecule

     Prostate Cancer (Adenocarcinoma)

     CT.gov ↗
472. NCT07381634

     ondansetron

     Phase 2 · active · small_molecule

     Hepatocellular Carcinoma (HCC)

     CT.gov ↗
473. NCT07386704

     Nimotuzumab combined with chemoradiotherapy

     Phase 2 · active · small_molecule

     Pancreatic Cancer Non-resectable

     CT.gov ↗
474. NCT07391826

     megestrol acetate oral suspension + serplulimab + SOX

     Phase 2 · active · small_molecule

     Stage III Gastric Cancer

     CT.gov ↗
475. NCT07396454

     Radiotherapy Combined with Anlotinib and a Microtubule Inhibitor

     Phase 2 · active · small_molecule

     HER2-Negative Breast Cancer

     CT.gov ↗
476. NCT07396480

     Venetoclax in combination with fludarabine and melphalan

     Phase 3 · active · small_molecule

     Venentoclax

     CT.gov ↗
477. NCT07398612

     Human Adipose-Derived Stem Cell Exosomes

     Phase 2 · active · mab

     Acute Ischemic Stroke

     CT.gov ↗
478. NCT07400315

     Iparomlimab and Tuvonralimab Injection in combination with TFOX

     Phase 2 · active · small_molecule

     Gastric or Gastroesophageal Junction Adenocarcinoma

     CT.gov ↗
479. NCT07400341

     Romiplostim

     Phase 2 · active · small_molecule

     MDS (Myelodysplastic Syndrome)

     CT.gov ↗
480. NCT07412171

     Toripalimab

     Phase 2 · active · small_molecule

     Upper Tract Urothelial Carcinoma

     CT.gov ↗
481. NCT07413809

     Fosaprepitant

     Phase 3 · active · small_molecule

     Multiple Myeloma

     CT.gov ↗
482. NCT07418177

     HiPSC-RPE cells

     Phase 2 · active · mab

     AMD - Age-Related Macular Degeneration

     CT.gov ↗
483. NCT07425782

     Ara-C Group

     Phase 2 · active · small_molecule

     Acute Myeloid Leukemia

     CT.gov ↗
484. NCT07448324

     Orelabrutinib

     Phase 2 · active · small_molecule

     Marginal Zone Lymphoma(MZL)

     CT.gov ↗
485. NCT07449156

     HB0043

     Phase 2 · active · small_molecule

     Acne Vulgaris

     CT.gov ↗
486. NCT07454018

     Iparomlimab/Tuvonralimab

     Phase 2 · active · small_molecule

     Recurrent Ovarian Cancer

     CT.gov ↗
487. NCT07455019

     2025-SR-813

     Phase 2 · active · small_molecule

     Esophageal Cancer

     CT.gov ↗
488. NCT07463651

     Gilteritinib

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia (AML)

     CT.gov ↗
489. NCT07464756

     SHR-1701

     Phase 2 · active · small_molecule

     Gastric Adenocarcinoma

     CT.gov ↗
490. NCT07471165

     PD -1/PD-L1 monoclonal antibody plus radiotherapy and liver transplantation

     Phase 2 · active · other

     Locally Advanced Perihilar Cholangiocarcinoma

     CT.gov ↗
491. NCT07486479

     Mitoxantrone Hydrochloride Liposome

     Phase 3 · active · small_molecule

     Acute Myeloid Leukemia (AML)

     CT.gov ↗
492. NCT07492342

     fulzerasib

     Phase 2 · active · small_molecule

     Resectable NSCLC

     CT.gov ↗
493. NCT07498907

     Disitamab Vedotin (RC48)

     Phase 2 · active · small_molecule

     Upper Tract Urothelial Carcinoma

     CT.gov ↗
494. NCT07505056

     Jianpi Lishi Jiedu Granules

     Phase 3 · active · small_molecule

     Colorectal Adenoma

     CT.gov ↗
495. NCT07509086

     IL-15-armored CAR-T cells

     Phase 2 · active · mab

     Relapsed/Refractory Multiple Myeloma

     CT.gov ↗
496. NCT07517276

     tauroursodeoxycholic acid (TUDCA)

     Phase 2 · active · small_molecule

     Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development

     CT.gov ↗
497. NCT07518810

     3-N-butylphthalide

     Phase 3 · active · small_molecule

     Multiple System Atrophy

     CT.gov ↗
498. NCT07523165

     Lifei Qingchang Granules

     Phase 2 · active · small_molecule

     Bronchiectasis

     CT.gov ↗
499. NCT07530003

     HUMSCs combined with bovine type I collagen

     Phase 2 · active · other

     Burn Wounds

     CT.gov ↗
500. NCT07530549

     QL1706

     Phase 2 · active · small_molecule

     Local Advanced Esophageal Cancer

     CT.gov ↗
501. NCT07534995

     the Shouhui Tongbian Capsule

     Phase 3 · active · small_molecule

     OIC

     CT.gov ↗
502. NCT07539792

     Absorbable and moldable skull base support plate

     Phase 2 · active · other

     Sellar Tumor

     CT.gov ↗
503. NCT07539805

     Sertraline combined with Lactobacillus crispatus

     Phase 2 · active · other

     Major Depressive Disorder (MDD)

     CT.gov ↗
504. NCT07540416

     TNK-tPA

     Phase 3 · active · small_molecule

     Acute Ischemic Stroke

     CT.gov ↗
505. NCT07550205

     Tiaoshen Anti-cancer Granules

     Phase 3 · active · small_molecule

     Ovarian Neoplasms Malignant

     CT.gov ↗
506. NCT07554898

     Orelabrutinib

     Phase 2 · active · small_molecule

     MALT Lymphoma

     CT.gov ↗
507. NCT07562568

     SHR2554/AZA + Overlapped TBF

     Phase 2 · active · other

     Acute Myeloid Leukemia

     CT.gov ↗
508. NCT07577986

     Chidamide Combined with NKG2D CAR-NK Cell Therapy

     Phase 2 · active · small_molecule

     HIV (Human Immunodeficiency Virus)

     CT.gov ↗
509. NCT07583589

     Nintedanib,Dextromethorphan

     Phase 2 · active · small_molecule

     Idiopathic Pulmonary Fibrosis (IPF)

     CT.gov ↗
510. NCT07599423

     Obinutuzumab

     Phase 2 · active · small_molecule

     Large B-cell Lymphoma

     CT.gov ↗
511. NCT07604350

     KY2025-328-02

     Phase 3 · active · small_molecule

     Post-stroke Epilepsy

     CT.gov ↗